Litcius/Paper detail

Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer

Aroa Duro‐Castaño, Ana Sousa‐Herves, Ana Armiñán, David Charbonnier, Juan J. Arroyo‐Crespo, Stefanie Wedepohl, Marcelo Calderón, Marı́a J. Vicent

2021Journal of Controlled Release59 citationsDOIOpen Access PDF

Topics & Concepts

Triple-negative breast cancerDoxorubicinPolyglutamic acidMetastatic breast cancerMedicineBreast cancerCancer researchDrug deliveryDrugMetastasisLymph nodePaclitaxelPharmacologyChemotherapyCancerInternal medicineChemistryMaterials scienceNanotechnologyBiochemistryNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsCancer Research and Treatments
Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer | Litcius